Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with
metastatic or recurrent head and neck cancer.